There is evidence that the life expectancy (LE) of individuals infected with the human
immunodeficiency virus (HIV) has increased since the introduction of combination …

Background The life expectancy of people with HIV taking antiretroviral therapy (ART) has
increased substantially over the past 25 years. Most previous studies of life expectancy were …

Background Health care for people living with HIV has improved substantially in the past two
decades. Robust estimates of how these improvements have affected prognosis and life …

The advent of highly active antiretroviral therapy (HAART) has significantly reduced the
incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several …

Background Substantial reductions in adult mortality have been observed in South Africa
since the mid-2000s, but there has been no formal evaluation of how much of this decline is …

Background We sought to evaluate life expectancy and mortality of HIV-positive individuals
initiating combination antiretroviral therapy (ART) across Canada, and to consider the …

Background. Patterns of cause-specific mortality in individuals infected with human
immunodeficiency virus type 1 (HIV-1) are changing dramatically in the era of antiretroviral …

Objectives To estimate mortality rates and prognostic factors in HIV-positive patients who
started combination antiretroviral therapy between 1996–1999 and survived for more than …

Background High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in
sub-Saharan Africa, compared to Europe and North America, is well documented. Longer …

The advent of effective combination antiretroviral therapy (ART) in 1996 resulted in fewer
patients experiencing clinical events, so that some prognostic analyses of individual cohort …